Western blot analyses of proteins extracted either from tumors generated by RKO/Par4 clones compared with RKO parental cells, or tumors generated by HCT116 aggressive colon cancer cells versus sh-silenced Par4 HCT116 cells were performed. This evidence concerns the gene F2RL3 and malignant colon neoplasm.